MeSH D006086 - graft vs host disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007154:Immune system diseases
D006086:Â
Graft vs host disease
D000092122:Bronchiolitis obliterans syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Methylprednisolone | Methylprednisolone |  | 1982-01-01 |  |  |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Abbott Biotherapeutics | Methylprednisolone | A-methapred |  | 1991-02-22 |  |  |
| Accord Healthcare | Mycophenolate mofetil | Mycophenolate Mofetil |  | 2009-05-04 |  |  |
| Tacrolimus | Tacrolimus |  | 2011-08-31 |  |  | |
| Mycophenolic acid | Mycophenolic |  | 2017-08-23 |  |  | |
| Alkem Laboratories | Mycophenolate mofetil | Mycophenolate Mofetil |  | 2011-11-04 |  |  |
| Tacrolimus | Tacrolimus |  | 2020-11-12 |  |  | |
| Mycophenolic acid | Mycophenolic |  | 2021-09-23 |  |  | |
| Allergan | Methylprednisolone | Methylprednisolone |  | 1997-10-16 |  |  |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| American Therapeutics | Prednisone | Prednisone |  | 1986-11-06 |  |  |
| Amneal Pharmaceuticals | Methylprednisolone | Methylprednisolone |  | 2021-09-21 |  |  |
| Mycophenolate mofetil | Mycophenolate Mofetil |  | 2010-07-16 |  |  | |
| Prednisone | Prednisone |  | 1987-10-05 |  |  | |
| Amta Laboratories | Mycophenolic acid | Mycophenolic |  | 2021-02-10 |  |  |
| Apotex | Mycophenolate mofetil | Mycophenolate Mofetil |  | 2009-04-22 |  |  |
| Mycophenolic acid | Mycophenolic |  | 2012-08-21 |  |  | |
| APP Pharmaceuticals | Methylprednisolone | Methylprednisolone |  | 1984-06-08 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
81%67/83
Phase 2
39%47/119
Phase 3
47%29/62
Approved: 9Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use